Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of proteins from the cytoplasm into the nucleus. [GOC:jl]
Negative regulation of protein import into nucleus is a crucial cellular process that controls the movement of proteins from the cytoplasm into the nucleus, where they can participate in a wide range of essential functions. This process is tightly regulated to ensure that only the appropriate proteins are transported into the nucleus, maintaining the integrity and functionality of the nuclear environment. The process involves several key components, including:
1. **Nuclear Pore Complexes (NPCs):** These intricate structures embedded in the nuclear envelope act as gates that selectively allow the passage of molecules between the cytoplasm and the nucleus. NPCs are composed of numerous proteins, forming a channel through which proteins can translocate.
2. **Nuclear Localization Signals (NLSs):** These specific amino acid sequences within proteins serve as "postal codes," targeting them for nuclear import. NLSs are recognized by import receptors, which mediate the interaction with NPCs.
3. **Import Receptors:** These proteins bind to NLSs on cargo proteins and interact with the NPCs, facilitating the translocation of the cargo across the nuclear envelope.
4. **Nuclear Transport Factor 2 (NTF2):** This chaperone protein assists in the recycling of import receptors back to the cytoplasm after delivering their cargo to the nucleus.
5. **Ran GTPase:** This protein plays a critical role in the import process, acting as a molecular switch that regulates the interaction between import receptors and NPCs. Ran GTPase cycles between GTP-bound (active) and GDP-bound (inactive) states. In its GTP-bound state, Ran interacts with import receptors, promoting their dissociation from cargo proteins inside the nucleus.
6. **Ran-Binding Proteins:** These proteins, including importin-beta, bind to Ran GTPase and facilitate its interaction with import receptors.
7. **GTPase-Activating Proteins (GAPs) and Guanine Nucleotide Exchange Factors (GEFs):** These proteins regulate the activity of Ran GTPase by stimulating its hydrolysis of GTP (GAPs) or by promoting the exchange of GDP for GTP (GEFs), respectively.
The negative regulation of protein import into the nucleus involves mechanisms that inhibit or reduce the rate of protein translocation. This regulation can occur at various levels, including:
- **Regulation of NLS Recognition:** Modifications of NLSs or the presence of NLS-masking proteins can prevent the recognition of import receptors.
- **Regulation of Import Receptor Availability:** Factors can influence the availability of import receptors, either by sequestering them or by promoting their degradation.
- **Regulation of NPC Function:** Modifications of NPCs or the interaction of NPC components with inhibitory proteins can impair their ability to mediate transport.
- **Regulation of Ran GTPase Activity:** Changes in the activity of Ran GTPase or its interacting proteins can disrupt the import process.
- **Regulation of Cargo Protein Conformation:** Modifications of cargo proteins, such as phosphorylation or acetylation, can alter their ability to interact with import receptors.
- **Regulation of the Nuclear Environment:** Changes in the pH, ionic composition, or presence of specific molecules within the nucleus can affect the import process.
- **Competition:** The presence of multiple cargo proteins competing for the same import receptors or NPCs can lead to decreased transport efficiency.
The precise mechanisms of negative regulation vary depending on the specific protein and cellular context. These mechanisms are often complex and involve intricate interactions between multiple components. This complexity ensures that protein import into the nucleus is tightly controlled, preventing uncontrolled protein movement and maintaining cellular homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
NAD-dependent protein deacetylase sirtuin-6 | An NAD-dependent protein deacylase sirtuin-6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8N6T7] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
niacinamide | nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
pyrazinamide | pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis. | monocarboxylic acid amide; N-acylammonia; pyrazines | antitubercular agent; prodrug |
pyrazinoic acid | pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide. pyrazinoic acid: active metabolite of pyrazinamide; structure | pyrazinecarboxylic acid | antitubercular agent; drug metabolite |
1-(4-nitrophenyl)piperazine | 1-(4-nitrophenyl)piperazine: structure in first source | ||
rubimaillin | rubimaillin : A benzochromene that is 2H-benzo[h]chromene which is substituted by two methyl groups at position 2, a methoxycarbonyl group at position 5, and a hydroxy group at position 6. Found in the Chinese medical plant Rubia cordifola, It has an anti-cancer effect by inhibition of TNF-alpha-induced NF-kappaB activation. It is also a dual inhibitor of acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2), but is more selective for the ACAT2 isozyme. rubimaillin: structure given in first source | benzochromene; methyl ester; phenols | acyl-CoA:cholesterol acyltransferase 2 inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; neuroprotective agent; NF-kappaB inhibitor; plant metabolite |
5-chloropyrazinamide | |||
trichostatin a | trichostatin A: chelates zinc ion in the active site of histone deacetylases, resulting in preventing histone unpacking so DNA is less available for transcription; do not confuse with TRICHOSANTHIN which is a protein; found in STREPTOMYCES | antibiotic antifungal agent; hydroxamic acid; trichostatin | bacterial metabolite; EC 3.5.1.98 (histone deacetylase) inhibitor; geroprotector |
(3R,5S)-fluvastatin | (3R,5S)-fluvastatin : A (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid diastereoisomer in which the stereocentres beta- and delta- to the carboxy group have R and S configuration, respectively. The drug fluvastatin is an equimolar mixture of this compound and its enantiomer. | (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; statin (synthetic) | |
ly2784544 | pyridazines |